IRRA Stock Overview
PT Itama Ranoraya Tbk trades in laboratory and pharmaceutical equipment, and medical devices in Indonesia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
PT Itama Ranoraya Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp496.00 |
| 52 Week High | Rp1,045.00 |
| 52 Week Low | Rp436.00 |
| Beta | 0.94 |
| 1 Month Change | 1.64% |
| 3 Month Change | -8.15% |
| 1 Year Change | -40.24% |
| 3 Year Change | -73.48% |
| 5 Year Change | n/a |
| Change since IPO | -11.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| IRRA | ID Healthcare | ID Market | |
|---|---|---|---|
| 7D | -5.5% | -3.4% | -0.7% |
| 1Y | -40.2% | -1.0% | 3.3% |
Return vs Industry: IRRA underperformed the ID Healthcare industry which returned -0.3% over the past year.
Return vs Market: IRRA underperformed the ID Market which returned 2.8% over the past year.
Price Volatility
| IRRA volatility | |
|---|---|
| IRRA Average Weekly Movement | 10.0% |
| Healthcare Industry Average Movement | 4.7% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in ID Market | 12.0% |
| 10% least volatile stocks in ID Market | 2.3% |
Stable Share Price: IRRA has not had significant price volatility in the past 3 months.
Volatility Over Time: IRRA's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of ID stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 221 | Heru Syarif | www.itama.co.id |
PT Itama Ranoraya Tbk trades in laboratory and pharmaceutical equipment, and medical devices in Indonesia. It offers electromedical and non-electromedical medical equipment, in vitro diagnostic products, and other products. The company’s products include Covid and infectious disease rapid test, abbott, auto disable syringe, disinfectant, and other products, as well as USG machine.
PT Itama Ranoraya Tbk Fundamentals Summary
| IRRA fundamental statistics | |
|---|---|
| Market cap | Rp747.88b |
| Earnings (TTM) | Rp5.20b |
| Revenue (TTM) | Rp696.30b |
143.9x
P/E Ratio1.1x
P/S RatioIs IRRA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IRRA income statement (TTM) | |
|---|---|
| Revenue | Rp696.30b |
| Cost of Revenue | Rp561.08b |
| Gross Profit | Rp135.22b |
| Other Expenses | Rp130.02b |
| Earnings | Rp5.20b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.45 |
| Gross Margin | 19.42% |
| Net Profit Margin | 0.75% |
| Debt/Equity Ratio | 52.1% |
How did IRRA perform over the long term?
See historical performance and comparison